“PD-1 Inhibitors in Recurrent or Metastatic Oral Squamous Cell Carcinoma: Clinical Evidence, Patient Selection, and Immune-Related Toxicities”. Journal of Oral Health and Dental Therapeutics 1, no. 1 (October 30, 2026): 27–31. Accessed November 6, 2026. https://msarjournals.com/index.php/johdt/article/view/13.